The genomes of more than 3000 of these bacteria have been mapped by scientists in order to better understand diseases and the mechanisms of antibiotic resistance.
Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.
A new study provides a unique look at a novel strategy — clinical trials in a dish — that bridges preclinical testing and clinical trials.
Sometimes a new company catches the eye, and this week that company is nference, a Cambridge MA-based start-up developing AI technology to discover and develop drugs more effectively. AI is no longer new in this space, so why does nference grab our attention?
New findings suggest that a person’s own immune system helps nudge him or her down the path toward Parkinson’s, and that restraining the immune system with drugs potentially could prevent the neurological disorder.
In a new multicenter clinical trial, a personalised vaccine improved the survival rates of some people with the deadly brain cancer glioblastoma.
A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study.
Bill Hinshaw has left his position as Executive Vice President of US Oncology at Novartis, to assume the role of CEO at Axcella Health.
Researchers who’ve created a kidney-on-a-chip explain why these kinds of devices are an improvement over traditional ways to test new drugs.
A team of researchers has unveiled a novel statistical algorithm, capable of identifying potential disease genes in a more accurate and cost-effective way.
Activating an olfactory receptor in prostate cancer cells causes them to morph into a more aggressive form.
Michigan based researchers identify long noncoding RNA transcript as important molecule in prostate cancer progression. If you’re new to noncoding RNAs and cancer, this might be useful to read first!